Gilenya (Fingolimod) Capsule


Indications and Reactions:

Role Indications Reactions
Primary
Multiple Sclerosis 88.3%
Relapsing-remitting Multiple Sclerosis 9.4%
Gait Disturbance 0.6%
Off Label Use 0.6%
Papilloma Viral Infection 0.6%
Secondary Progressive Multiple Sclerosis 0.6%
Fatigue 12.9%
Visual Impairment 10.3%
Multiple Sclerosis Relapse 9.0%
White Blood Cell Count Decreased 6.5%
Heart Rate Decreased 5.2%
Macular Oedema 5.2%
No Adverse Event 5.2%
Somnolence 5.2%
Malaise 4.5%
Multiple Sclerosis 3.9%
Nausea 3.9%
Paraesthesia 3.9%
Pyrexia 3.9%
Infection 3.2%
Pain In Extremity 3.2%
Rash 3.2%
Vision Blurred 3.2%
Bradycardia 2.6%
Herpes Zoster 2.6%
Liver Function Test Abnormal 2.6%

Drug Data